These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19481884)

  • 1. Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment.
    Stein BD; Kogan JN; Sorbero M
    Drug Alcohol Depend; 2009 Sep; 104(1-2):100-6. PubMed ID: 19481884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?
    Reif S; Acevedo A; Garnick DW; Fullerton CA
    Psychiatr Serv; 2017 Aug; 68(8):810-818. PubMed ID: 28412900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis.
    Larson MJ; Paasche-Orlow M; Cheng DM; Lloyd-Travaglini C; Saitz R; Samet JH
    Addiction; 2007 May; 102(5):752-60. PubMed ID: 17506152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicaid managed care, substance abuse treatment, and people with disabilities: review of the literature.
    Bachman SS; Drainoni ML; Tobias C
    Health Soc Work; 2004 Aug; 29(3):189-96. PubMed ID: 15453057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between Residential Mobility and Behavioral Health Service Use in a National Sample of Adults With Mental Health and/or Substance Abuse Problems.
    Yuan Y; Manuel JI
    J Dual Diagn; 2018; 14(4):201-210. PubMed ID: 30303466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Outcomes of Young Adult Opiate Users Receiving Residential Substance Abuse Treatment.
    Morse S; MacMaster S
    J Evid Inf Soc Work; 2015; 12(6):556-66. PubMed ID: 25879396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of residential treatment of substance abuse in hospital- and community-based programs.
    Moos RH; King MJ; Patterson MA
    Psychiatr Serv; 1996 Jan; 47(1):68-74. PubMed ID: 8925349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A performance measure for continuity of care after detoxification: relationship with outcomes.
    Lee MT; Horgan CM; Garnick DW; Acevedo A; Panas L; Ritter GA; Dunigan R; Babakhanlou-Chase H; Bidorini A; Campbell K; Haberlin K; Huber A; Lambert-Wacey D; Leeper T; Reynolds M
    J Subst Abuse Treat; 2014 Aug; 47(2):130-9. PubMed ID: 24912862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious mental illness and risk of new HIV/AIDS diagnoses: an analysis of Medicaid beneficiaries in eight states.
    Prince JD; Walkup J; Akincigil A; Amin S; Crystal S
    Psychiatr Serv; 2012 Oct; 63(10):1032-8. PubMed ID: 22855268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive validity of two process-of-care quality measures for residential substance use disorder treatment.
    Harris AH; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Rubinsky AD; Finney JW; Asch SM; Humphreys K; Trafton J
    Addict Sci Clin Pract; 2015 Oct; 10():22. PubMed ID: 26520402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State policy and practice regarding substance abuse treatment services for medicaid recipients with disabilities.
    Bachman SS; Drainoni ML; Tobias C
    Am J Addict; 2003; 12(2):166-76. PubMed ID: 12746092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mental health care and substance abuse treatment among adults with co-occurring disorders.
    Harris KM; Edlund MJ
    Psychiatr Serv; 2005 Aug; 56(8):954-9. PubMed ID: 16088012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting attrition in long-term residential substance use disorder treatment: A modifiable risk factors perspective.
    Baker DE; Edmonds KA; Calvert ML; Sanders SM; Bridges AJ; Rhea MA; Kosloff S
    Psychol Serv; 2020 Nov; 17(4):472-482. PubMed ID: 30816739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mental health and substance abuse treatment services among adults with HIV in the United States.
    Burnam MA; Bing EG; Morton SC; Sherbourne C; Fleishman JA; London AS; Vitiello B; Stein M; Bozzette SA; Shapiro MF
    Arch Gen Psychiatry; 2001 Aug; 58(8):729-36. PubMed ID: 11483138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.